Connection

Christopher Koivisto to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Christopher Koivisto has written about Carcinoma, Hepatocellular.
Christopher Koivisto
Connection Strength
0.232
Carcinoma, Hepatocellular
  1. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017 Mar 01; 127(3):830-842.
    View in: PubMed
    Score: 0.118
  2. E2f8 mediates tumor suppression in postnatal liver development. J Clin Invest. 2016 08 01; 126(8):2955-69.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.